TSLPR antibody inhibits platelet function and atherothrombosis in ApoE-/-mice

Bo-Yuan WANG,Chun WU,Shao-Lin HE,Kai HUANG,Da-Zhu LI
DOI: https://doi.org/10.3969/j.issn.1000-484X.2016.11.001
2016-01-01
Abstract:Objective:To explore the role of TSLPR antibody in the atherothrombosis inhibition.Methods: 8 weeks old ApoE-/-mice were fed with high-cholesterol diet for 12 weeks.During this time,mice in different groups were injected periodically with TSLPR antibody or isotype IgG respectively.The time of atherothrombosis ,platelet aggregation function ,platelet release function ,and the expression of platelet membrane glycoprotein in different groups were detected.Results:Compared with those in the IgG control group , in the TSLPR antibody group the time of atherothrombosis was prolonged ,the function of platelet aggregation and release was weakened , the expression of CD62p,CD63,PAC-1 was decreased,the expression of CD42b was increased.Conclusion:TSLPR antibody injection could inhibit atherosclerosis thrombus formation via weakening platelet aggregation and release function and repressing platelet activa -tion.
What problem does this paper attempt to address?